Early diagnosis of 5α-reductase deficiency in newborns

Sexual Development

Volumn 1, Issue 3, 2007, Pages 147-151

  Bertelloni, S ^a   Scaramuzzo, R T ^a   Parrini, D ^a   Baldinotti, F ^a   Tumini, S ^b   Ghirri, P ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF CHIETI   (Italy)

Author keywords

46,XY disorders of sex differentiation; 5 reductase deficiency; 5 reductase type 2 gene analysis; Testosterone dihydrotestosterone ratio

Indexed keywords

ANDROSTANOLONE; STEROID 5ALPHA REDUCTASE; TESTOSTERONE; STEROID 5ALPHA REDUCTASE 2; STEROID-5ALPHA-REDUCTASE TYPE 2;

ARTICLE; CONTROLLED STUDY; DNA POLYMORPHISM; EARLY DIAGNOSIS; ENZYME DEFICIENCY; EXON; FEMALE; GENE MUTATION; GENETIC ANALYSIS; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; KARYOTYPE 46,XY; MALE; MOLECULAR GENETICS; NEWBORN; PRIORITY JOURNAL; ENZYMOLOGY; PSEUDOHERMAPHRODITISM;

FEMALE; HUMANS; INFANT, NEWBORN; MALE; PSEUDOHERMAPHRODITISM; TESTOSTERONE 5-ALPHA-REDUCTASE;

EID: 34547764772     PISSN: 16615425     EISSN: 16615433     Source Type: Journal    
DOI: 10.1159/000102103     Document Type: Article

References (31)

1. Ahmed SF, Cheng A, Dovey L, Hawkins JR, Martin H, et al: Phenotypic features, androgen receptor binding, and mutational analysis in 278 clinical cases reported as androgen insensitivity syndrome. J Clin Endocrinol Metab 85:658-665 (2000).
2. Albers N, Ulrichs C, Gluer S, Hiort O, Sinnecker GH, et al: Etiologic classification of severe hypospadias: implications for prognosis and management. J Pediatr 13:386-392 (1997).
3. Cantu JM, Hernandez-Montes H, del Castillo V, Sandoval R, et al: Potential fertility in incomplete male pseudohermaphroditism type 2. Rev Invest Clin 28:177-182 (1976).
4. Carpenter TO, Imperato-McGinley J, Boulware SD, Weiss RM, Shackleton CHL, Wilson JD: Variable expression of 5 alpha-reductase deficiency: presentation with male phenotype in a child of Greek origin. J Clin Endocrinol Metab 71:318-322 (1990).
5. Carrillo AA, Danon A, Berkovitz GD: Disorders of sexual differentiation; in Lifshitz F (ed): Pediatric Endocrinology, pp 319-345 (M. Dekker Inc., New York 2003).
6. Cohen-Kettenis PT: Gender change in 46,XY persons with 5alpha-reductase-2 deficiency and 17beta-hydroxysteroid dehydrogenase-3 deficiency. Arch Sex Behav 34:399-410 (2005).
7. Consortium on the Management of Disorders of Sex Differentiation: Clinical guidelines for the management of disorders of sex differentiation in childhood. www.dsdguidelines.org (2005).
8. Fernandez-Cancio M, Rodo J, Andaluz P, Martinez de Osaba MJ, Rodriguez-Hierro F, et al: Clinical, biochemical and morphologic diagnostic markers in an infant male pseudohermaphrodite patient with compound heterozygous mutations (G115D/R246W) in SRD5A2 gene. Horm Res 62:259-264 (2004).
9. Grumbach MM: A window of opportunity: the diagnosis of gonadotropin deficiency in the male infant: J Clin Endocrinol Metab 90:3122-3127 (2005).
10. Hackel C, Oliveira LE, Ferraz LF, Tonini MM, Silva DN, et al: New mutations, hotspots, and founder effects in Brazilian patients with steroid 5alpha-reductase deficiency type 2. J Mol Med 83:569-576 (2005).
11. Hochberg Z, Chayen R, Reiss N, Falik Z, Makler A, et al: Clinical, biochemical, and genetic findings in a large pedigree of male and female patients with 5 alpha-reductase 2 deficiency. J Clin Endocrinol Metab 81:2821-2827 (1996).
12. Hughes IA, Houk C, Ahmed SF, Lee PA, LWPES/ESPE Consensus Group: Consensus statement on management of intersex disorders. Arch Dis Child 91:554-563 (2006).
13. Imperato-McGinley J, Zhu YS: Androgens and male physiology the syndrome of 5α-reductase-2 deficiency. Mol Cell Endocrinol 198:51-59 (2002).
14. Imperato-McGinley J, Peterson RE, Gautier T, Sturla E: Male pseudohermaphroditism secondary to 5α-reductase deficiency: a model for the role of androgens in both the development of the male phenotype and the evolution of a male gender identity. J Steroid Biochem Mol Biol 11:37-45 (1979).
15. Imperato-McGinley J, Peterson RE, Leshin M, Griffin JE, Cooper G, et al: Steroid 5α-reductase deficiency in a 65-year old male pseudohermaphrodite: the natural history, ultrastructure of the testes and evidence for inherited enzyme heterogeneity. J Clin Endocrinol Metab 50:15-22 (1980).
16. Katz MD, Kligman I, Cai LQ, Zhu YS, Fratianni CM, et al: Paternity by intrauterine insemination with sperm from a man with 5alpha-reductase-2 deficiency. N Engl J Med 336:994-997 (1997).
17. Mazen I, Gad YZ, Hafez M, Sultan C, Lumbroso S: Molecular analysis of 5alpha-reductase type 2 gene in eight unrelated Egyptian children with suspected 5alpha-reductase deficiency: prevalence of the G34R mutation. Clin Endocrinol 58:627-631 (2003).
18. Morel Y, Rey R, Teinturier C, Nicolino M, Michel-Calemard L, et al: Aetiological diagnosis of male sex ambiguity: a collaborative study. Eur J Pediatr 161:49-59 (2002).
19. Ng WK, Taylor NF, Hughes IA, Taylor J, Ransley PG, Grant DB: 5α-reductase deficiency without hypospadias. Arch Dis Child 65:1166-1167 (1990).
20. Nicoletti A, Baldazzi L, Balsamo A, Barp L, Pirazzoli P, et al: SRD5A2 gene analysis in an Italian population of under-masculinized 46,XY subjects. Clin Endocrinol (Oxf) 63:375-380 (2005).
21. Nordenskjold A, Ivarsson SA: Molecular characterization of 5 alpha-reductase type 2 deficiency and fertility in a Swedish family. J Clin Endocrinol Metab 83:3236-3238 (1998).
22. Ocal G, Adiyaman P, Berberoglu M, Cetinkaya E, Akar N, et al: Mutations of the 5alpha-steroid reductase type 2 gene in six Turkish patients from unrelated families and a large pedigree of an isolated Turkish village. J Pediatr Endocrinol Metab 15:411-421 (2002).
23. Odame I, Donaldson MD, Wallace AM, Cochran W, Smith PJ: Early diagnosis and management of 5 alpha-reductase deficiency. Arch Dis Child 67:720-723 (1992).
24. Pang S, Levine LS, Chow D, Sagiani F, Saenger P, New MI: Dihydrotestosterone and its relationship to testosterone in infancy and childhood. J Clin Endocrinol Metab 48:821-826 (1979).
25. Schonfeld WA, Beebe GW: Normal growth and variation in the male genitalia from birth to maturity. J Urol 48:759-777 (1942).
26. Sinnecker GH, Hiort O, Dibbelt L, Albers N, Dorr HG, et al: Phenotypic classification of male pseudohermaphroditism due to steroid 5alpha-reductase 2 deficiency. Am J Med Genet 63:223-230 (1996).
27. Skordis N, Patsalis PC, Bacopoulou I, Sismani C, Sultan C, Lumbroso S: 5alpha-reductase 2 gene mutations in three unrelated patients of Greek Cypriot origin: identification of an ancestral founder effect. J Pediatr Endocrinol Metab 18:241-246 (2005).
28. Thiele S, Hoppe U, Holterhus PM, Hiort O: Isoenzyme type 1 of 5alpha-reductase is abundantly transcribed in normal human genital skin fibroblasts and may play an important role in masculinization of 5alpha-reductase type 2 deficient males. Eur J Endocrinol 152:875-880 (2005).
29. Vilchis F, Mendez JP, Canto P, Lieberman E, Chavez B: Identification of missense mutations in the SRD5A2 gene from patients with steroid 5alpha-reductase 2 deficiency. Clin Endocrinol 52:383-387 (2000).
30. Werner R, Holterhus PM, Struve D, Hiort O: Interplay of androgen receptor polymorphic poly glutamine and poly glycine tracts acts as determinant of androgen insensitivity in humans. Horm Res 64(S1):25 (abs) (2005).
31. Wilson JD, Griffin JE, Russell DW: Steroid 5 alpha-reductase 2 deficiency. Endocr Rev 14:577-593 (1993).